Trial Profile
Efficacy of PEG-epoetin beta switched from darbepoetin alfa in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms AFFIRM Study
- 09 Apr 2015 New trial record